Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery

被引：15

作者：

Randelli F. ^{[1
]}

Biggi F. ^{[2
]}

Della Rocca G. ^{[3
]}

Grossi P. ^{[4
]}

Imberti D. ^{[5
]}

Landolfi R. ^{[6
]}

Palareti G. ^{[7
]}

Prisco D. ^{[8
,9
]}

机构：

[1] Hip Department, Orthopedics and Trauma II, IRCCS Policlinico San Donato, Milan, S. Donato Milanese

[2] Orthopaedic and Trauma Department, Belluno Hospital, Belluno

[3] Anesthesia and Intensive Care Medicine, University of Udine, Udine

[4] Regional Anesthesia and Pain Therapy Department, IRCCS Policlinico San Donato, Milan, S. Donato Milanese

[5] Internal Medicine Department, University Hospital of Ferrara, Ferrara

[6] Department of Internal Medicine, University Hospital A. Gemelli, Rome

[7] Unit of Angiology and Coagulation Disease, AOU sant'Orsola-Malpighi, University of Bologna, Bologna

[8] Department of Internal Medicine, University of Florence, Florence

[9] Thrombosis Regional Reference Centre, Careggi University Hospital, Florence

来源：

Journal of Orthopaedics and Traumatology | 2011年 / 12卷 / 1期

关键词：

Anticoagulant prophylaxis; Dabigatran; Enoxaparin; Femoral neck fractures; Prevention of venous thromboembolism; Rivaroxaban; Total hip replacement; Total knee replacement;

D O I：

10.1007/s10195-010-0125-8

中图分类号：

学科分类号：

摘要：

Anticoagulant prophylaxis for preventing venous thromboembolism (VTE) is a worldwide established procedure in hip and knee replacement surgery, as well as in the treatment of femoral neck fractures (FNF). Different guidelines are available in the literature, with quite different recommendations. None of them is a multidisciplinary effort as the one presented. The Italian Society for Studies on Haemostasis and Thrombosis (SISET), the Italian Society of Orthopaedics and Traumatology (SIOT), the association of Orthopaedists and Traumatologists of Italian Hospitals (OTODI), together with the Italian Society of Anesthesia, Analgesia, Resuscitation, and Intensive Care (SIAARTI) have set down easy and quick suggestions for VTE prophylaxis in hip and knee surgery as well as in FNF treatment. This inter-society consensus statement aims at simplifying the grading system reported in the literature, and its goal is to benefit its clinical application. Special focus is given to fragile patients, those with high bleeding risk, and those receiving chronic antiplatelet (APT) and vitamin K antagonists treatment. A special chapter is dedicated to regional anaesthesia and VTE prophylaxis. © 2011 The Author(s).

引用

页码：69 / 76

页数：7

共 24 条

[1]

Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., Colwell C.W., Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 6 SUPPL. 6, (2008)

[2]

Prisco D., Violi F., Linee Guida per la Profilassi Del Tromboembolismo Venoso in Chirurgia Ortopedica Maggiore: Cosa Pensa la Società Italiana per Lo Studio dell'Emostasi e della Trombosi. Haematologica, 87, SUPPL. 4, pp. 11-13, (2002)

[3]

Prisco D., Linee Guida per la Diagnosi, la Profilassi e la Terapia Del Tromboembolismo Venoso. Haematologica, 88, SUPPL. 18, pp. 1-61, (2003)

[4]

International consensus statement, Int Angiol, 25, pp. 1001-1161, (2006)

[5]

Hill J., Treasure T

[6]

National Clinical Guideline Centre for acute and chronic conditions, Reducing the Risk of Venous Thromboembolism in Patients Admitted to Hospital: Summary of NICE Guidance. BMJ, 340, (2010)

[7]

Strebel N., Prins M., Agnelli G., Buller H.R., Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?, Archives of Internal Medicine, 162, 13, pp. 1451-1456, (2002)

[8]

Raskob G.E., Hirsh J., Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism after Major Orthopedic Surgery, Chest, 124, 6 SUPPL., (2003)

[9]

Turpie A.G., Bauer K.A., Eriksson B.I., Lassen M.R., Fondaparinux versus enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery, Arch Intern Med, 162, pp. 1833-1840, (2002)

[10]

Colwell Jr. C.W., Kwong L.M., Turpie A.G.G., Davidson B.L., Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery, Journal of Arthroplasty, 21, 1, pp. 36-45, (2006)

← 1 2 3 →